GlassScriptPhysician profile
Mary M Johnson
NPI 1356978563
$1,105.10
in general payments reported to CMS, 2019-2025
19 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.54 · 2023: $66.28 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $178.31 | 2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $149.82 | 2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $138.34 | 2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $135.92 | 2025 | Evenity, Repatha, Otezla |
| Astellas Pharma US INC | $74.77 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $53.63 | 2025 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $50.06 | 2025 | Rexulti |
| Sumitomo Pharma America, INC. | $49.43 | 2025 | Gemtesa |
| Inspire Medical Systems, INC. | $40.81 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $39.56 | 2025 | Verquvo |
| Medtronic, INC. | $35.50 | 2025 | Minimed 780g |
| Abbvie INC. | $30.09 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.94 | 2025 | |
| Dexcom, INC. | $20.95 | 2023 | Dexcom G6 Transmitter |
| Tactile Systems Technology INC | $20.54 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $16.76 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.85 | 2023 | Xarelto |
| Collegium Pharmaceutical, INC. | $14.10 | 2025 | Jornay Pm |
| Paratek Pharmaceuticals, INC. | $13.72 | 2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.